MarkNtel Advisors’ industry professionals present a comprehensive and professional study of the Cardiac Ablation Devices Market. The study is a perfect blend of quantitative and qualitative data that highlights the industry’s competition as well as gap analysis, key market developments, challenges, new opportunities, and market trends. The Cardiac Ablation Devices Market is anticipated to experience a CAGR of 16.53% during the forecast period 2022-2027.
The research provides a thorough examination of the Cardiac Ablation Devices Market and highlights significant shifts or trends for industries, suppliers, associations, and organizations. Based on revenue, demand, sales, product manufacturers, and service providers, the research provides unique information on key market rivals and emerging firms with significant market share. The report focuses on general data that can be used to make market-related decisions.
Take A Free Sample PDF of this Study Report, To Complete Understanding About This Study – Download Sample Report PDF Now
|Study Period||Historical Data: 2017-20|
|Base Year: 2021|
|Forecast Period: 2022-27|
|Regions Covered||North America: USA, Canada, Mexico|
|Europe: Germany, UK, Spain, France, Italy|
|Asia-Pacific: China, Japan, India, South Korea, Australia, Rest of Asia Pacific|
|South America: Brazil, Rest of South America|
|Middle East & Africa: UAE, Saudi Arabia, South Africa, Rest of Middle East & Africa|
|Key Companies Profiled||Abbott Laboratories, Medtronic plc, Olympus Corporation, Johnson & Johnson (Biosense Webster, Inc.), Boston Scientific Corporation, CONMED Corporation, AngioDynamics, Inc., CardioFocus Inc., Stryker Corporation, MicroPort Inc., Stereotaxis Inc., Teleflex Incorporated, Lepu Medical Technology, Avanos Medical, AtriCure Others|
|Unit Denominations||USD Million/Billion|
Key Objective of this Research Report –
- To provide in-depth information on the critical factors influencing market growth.
- To evaluate the market competition, including new product/service launches, market expansions, contracts, and acquisitions.
- To examine the market in terms of distinct growth trends, market share contributions, and potential future growth.
- To develop a strategic profile of the major market players and conduct an in-depth analysis of their expansion plans.
- The value of a product or service will be determined by key segments and geographical areas using historical data and projections through 2027.
- Recognizing the numerous sub-segments within the Cardiac Ablation Devices market is required to comprehend its structure.
- Identify, characterize, and analyze major market players’ market share, market value, competitive landscape, SWOT analysis, Porter’s Five Forces analysis, and expansion plans over the forecast period.
- To forecast the dominance and growth of major geographic regions (together with each of their primary countries).
This study provides a thorough review of the Cardiac Ablation Devices market analysis. The report’s market projections are the result of an in-depth investigation, interviews, and internal expert evaluations. These market estimations were created by looking into the numerous political, social, and economic aspects that have shaped the market’s growth as well as current market trends.
Market Ongoing Trends – The Robotic Navigation System is 70% to 80% faster than the previous one & offers more flexibility. This system allows optimal catheter stability and reproducible catheter movements to obtain better results. The system has been efficient in doing ablation of both simple and complex arrhythmias, mainly atrial fibrillation. The usage of robotic navigation systems has been announced by several companies specializing in cardiac ablation devices. In addition, the FDA approval on their usage has also been registering an uptrend. For instance, the Stereotaxis robotic navigation of magnetic ablation catheter received FDA approval in 2020.
Regional Growth Data – Cardiac Ablation Devices Market is divided into North America, South America, Europe, Asia Pacific, the Middle East & Africa region. Of all regions globally, North America acquired the highest share in the Cardiac Ablation Device Market in the historical period since it is an early adopter of advanced technologies in cardiac ablation. Favorable reimbursement policies for cardiac ablation procedures, the extensive presence of giant market players like Johnsons & Johnsons, Abbott, CardioFocus, etc., and mounting incidences of cardiac diseases, especially AFib, in the geriatric population, are the prime factors driving the regional market.
- According to the Centers for Disease Control and Prevention (CDC), Atrial Fibrillation (AFib) was the underlying cause of death of around 26,535 people in 2019. Along with this, the prevalence of AFib in the United States is estimated to rise to 12.1 million in 2030.
Market Growth Factor – Atrial Fibrillation (AF) has been a common type of arrhythmia in which the heart beats rapidly or slowly. It can either result in strokes or heart failure and happens mainly due to excessive intake of alcohol & caffeine, sedentary lifestyle, smoking, consumption of dietary supplements, etc. Due to this, heart diseases, high blood pressure, chronic heart diseases, thyroid, obesity, etc., have increased substantially. AF often coexists with heart failure as well as obesity in the aging population.
Moreover, the prevalence of AF is higher among people aged 65 & above. The escalating geriatric population in both developed & developing countries like the US, Japan, countries of Western Europe, and India & China are expected to propel the incidence rate of AF in the coming years.
For Your Any Question or Further Discussion About This Market Study Report, Schedule A Call with Our Analyst Here – Send Your Call Back Request Now
Table of Content
- Research Process
- Market Segmentation
- Market Definition
- Executive Summary
- Global Cardiac Ablation Device Market Trends & Insights
- Global Cardiac Ablation Device Market Regulation & Policy, By Country
- Global Cardiac Ablation Device Market Dynamics
- Growth Drivers
- Impact Analysis
- Global Cardiac Ablation Device Market Hotspot and Opportunities
- Global Cardiac Ablation Device Market Outlook, 2017- 2027
Market Top Participants Analysis
The report gives important information that can be used to better understand the market and design effective corporate expansion strategies. In-depth analysis of both recent market entrants and current competitors in the Cardiac Ablation Devices industry is provided in this section, which also addresses important issues like market positioning and potential growth strategies. The study examines the competitive environment of the Cardiac Ablation Devices market and provides detailed profiles of the key players. The companies listed are as follows:
- – Abbott Laboratories
- – Medtronic plc
- – Olympus Corporation
- – Johnson & Johnson (Biosense Webster, Inc.)
- – Boston Scientific Corporation
- – CONMED Corporation
- – AngioDynamics, Inc.
- – CardioFocus Inc.
- – Stryker Corporation
- – MicroPort Inc.
- – Stereotaxis Inc.
- – Teleflex Incorporated
- – Lepu Medical Technology
- – Avanos Medical
- – AtriCure
- – Others
Some of The Latest Market Development Done By Market Leader –
- In 2022, Medtronic acquired Affera Inc. to expand its cardiac ablation portfolio. Affera designs & manufactures electrophysiology (EP) cardiac mapping & navigation systems and catheter-based cardiac ablation technologies. The company aims to establish its footprint in the cardiac ablation space.
- In 2020, Biosense Webster launched CARTO 3 System Version 7 and the CARTO PRIME mapping module to advance the treatment of complex arrhythmias. CARTO PRIME is powered with improvised mapping capabilities that help significantly reduce ablation times compared to standard mapping algorithms.
Complete Segmentation Study
Precise statistical information, facts, trends, statistics, and industry segmentation insights are all included in the research. It focuses on, examines, and offers a geographical analysis of the key market segments. The following criteria are used to categorise the market under study: –
- Water-cooled radiofrequency ablation
- Temperature-Controlled Radiofrequency Ablators
- Tissue Contact Probes
- Microwave Thermotherapy Devices
- Others (Robotic Catheter Manipulation Systems, Ultrasound Ablation Systems, etc.)
- Radiofrequency (RF) Ablation
- Cryoablation Device
- Laser Ablation
- Electrical Ablators
- Microwave Ablation
- Ultrasound Ablation
- Cardiac Rhythm Management
- Atrial Fibrillation and Flutter
- Open Surgery
Understanding the categories makes it simpler to recognize the importance of numerous factors that influence market growth.
More Study –
Customization Service We Offer
In order to help our clients accurately understand the important opportunities, handle growth issues, and make informed decisions to remain competitive in the market, we also provide reports customization services with customized & high-quality insights as per their unique requirements.
To Get The Benefit or Our Customization Service, Sent Your Enquiry Here – https://www.marknteladvisors.com/query/request-customization/cardiac-ablation-devices-market.html
About MarkNtel Advisors
We are a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Our Contact Details –
Phone – +1 628 895 8081, +91 120 4278433
Follow Us – Twitter, LinkedIn, Facebook, Pinterest
Read Blogs – www.marknteladvisors.com/blogs